Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis Elbaz

Showing results (171-180 of 194) with videos related to

Pageof 20
Sort By:
Environment International|December 14, 2022
Long-term air pollution exposure and Parkinson's disease mortality in a large pooled European cohort: An ELAPSE studyThomas Cole-Hunter, Jiawei Zhang, Rina So, et al.
NPJ Parkinson'S Disease|June 7, 2024
Genome-wide determinants of mortality and motor progression in Parkinson's diseaseManuela M X Tan, Michael A Lawton, Miriam I Pollard, et al.
Medrxiv : the Preprint Server for Health Sciences|September 5, 2025
Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvementJan Homann, Roxanna Korologou-Linden, Vivian Viallon, et al.
NPJ Parkinson'S Disease|May 14, 2026
Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohortsXiaoying Kang, Zechuan Lin, Fatma Zehra Calikusu, et al.
Research Square|September 15, 2025
Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvementJan Homann, Roxanna Korologou-Linden, Vivian Viallon, et al.
Annals of Neurology|March 11, 2011
Independent and joint effects of the MAPT and SNCA genes in Parkinson diseaseAlexis Elbaz, Owen A Ross, John P A Ioannidis, et al.
Aging|April 23, 2019
Socioeconomic position, lifestyle habits and biomarkers of epigenetic aging: a multi-cohort analysisGiovanni Fiorito, Cathal McCrory, Oliver Robinson, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Large-scale plasma proteomics uncovers preclinical molecular signatures of Parkinson's disease and overlap with other neurodegenerative disordersJan Homann, Alexander G Smith, Sarah Morgan, et al.
Neurobiology of Aging|August 22, 2013
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variantsMichael G Heckman, Alexis Elbaz, Alexandra I Soto-Ortolaza, et al.
The Lancet. Neurology|September 3, 2011
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control studyOwen A Ross, Alexandra I Soto-Ortolaza, Michael G Heckman, et al.
Pageof 20

Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Environment International|December 14, 2022
Long-term air pollution exposure and Parkinson's disease mortality in a large pooled European cohort: An ELAPSE studyThomas Cole-Hunter, Jiawei Zhang, Rina So, et al.
NPJ Parkinson'S Disease|June 7, 2024
Genome-wide determinants of mortality and motor progression in Parkinson's diseaseManuela M X Tan, Michael A Lawton, Miriam I Pollard, et al.
Medrxiv : the Preprint Server for Health Sciences|September 5, 2025
Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvementJan Homann, Roxanna Korologou-Linden, Vivian Viallon, et al.
NPJ Parkinson'S Disease|May 14, 2026
Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohortsXiaoying Kang, Zechuan Lin, Fatma Zehra Calikusu, et al.
Research Square|September 15, 2025
Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvementJan Homann, Roxanna Korologou-Linden, Vivian Viallon, et al.
Annals of Neurology|March 11, 2011
Independent and joint effects of the MAPT and SNCA genes in Parkinson diseaseAlexis Elbaz, Owen A Ross, John P A Ioannidis, et al.
Aging|April 23, 2019
Socioeconomic position, lifestyle habits and biomarkers of epigenetic aging: a multi-cohort analysisGiovanni Fiorito, Cathal McCrory, Oliver Robinson, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Large-scale plasma proteomics uncovers preclinical molecular signatures of Parkinson's disease and overlap with other neurodegenerative disordersJan Homann, Alexander G Smith, Sarah Morgan, et al.
Neurobiology of Aging|August 22, 2013
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variantsMichael G Heckman, Alexis Elbaz, Alexandra I Soto-Ortolaza, et al.
The Lancet. Neurology|September 3, 2011
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control studyOwen A Ross, Alexandra I Soto-Ortolaza, Michael G Heckman, et al.
Pageof 20